A study reported that IDO1 blockage could overcome radiation-induced “Rebound Immune Suppression” in the tumor microenvironment and sensitized Lewis lung carcinoma (LLC) tumors to hypo-fractionated RT [30]. The gene discussed is IDO1; the disease is Carcinoma, Lewis Lung.